Pacira BioSciences Reports Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira BioSciences Reports Second Quarter 2022 Financial Results

Pacira Pharma (PCRX) Misses Q2 EPS by 35c

August 3, 2022 8:06 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q2 EPS of $0.53, $0.35 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $169.4 million versus the consensus estimate of $172.22 million.

For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.

... More